Why Wayne-based Bracket acquired this DC company

In deal worth valued “in the 10 to 100 million range,” Wayne-based Bracket acquired D.C.-based mProve Health, a provider of mobile tech for life science companies and makers of a patient engagement solution used by 18 of the top 20 pharmaceutical companies.

No layoffs are expected as part of the deal. Instead, Bracket CTO Sam Whitaker said the company would start building up the mProve team, which currently has 33 employees. It aims to double that number in the next six months.

“The most interesting part [of the deal] is that we’re able to pick up functionalities that we think are market-leading in patient engagement,” said Whitaker, who’s also the founder of  another company in the field of clinical trials: King of Prussia-based Greenphire.

Bracket employs about 800, split between its Wayne HQ, Trevose, Pa., Boston, San Francisco, San Diego and other U.S. towns. It also has outposts in Prague and India.

“As an early adopter of mHealth and BYOD [Bring Your Own Device, a growing trend in clinical trials], we recognize how these movements empower patients to become partners in their trials, and subsequently, deliver more accurate patient-reported outcomes and increase the likelihood of a successful trial,” said Bracket CEO Jeff Kinell in a press release.

For now, mProve will retain its branding and become “mProve, a Bracket Company.” There are strategies in mind to combine the D.C. company’s technology with Bracket’s own suite of solutions.

In 2013, the Wayne-based technology firm was acquired by private equity firm Parthenon Capital Partners, which has offices in Boston and San Francisco. In March, the company was again acquired by San Francisco-based Genstar Capital.